After navigating egg freezing herself, GenPrime founder Margaret Wang saw an opportunity to rethink how fertility care is delivered across Asia—less fragmented, more compassionate and deeply patient-led
The journey into reproductive health began with a personal experience. After freezing her eggs in New York, Margaret Wang noticed how fragmented the fertility journey could feel in Southeast Asia. While medical expertise was abundant, the process—from initial inquiry to diagnostics and treatment—often spanned multiple clinics.
Wang faced significant early challenges. Fertility is highly specialised, and operating across multiple countries meant navigating varied regulations, medical practices and cultural attitudes. Yet her biggest breakthrough came from building a team aligned in philosophy and care, where doctors, embryologists, nurses and coordinators work collaboratively rather than in silos.
What sets GenPrime apart is its focus on the patient experience. Wang made sure her clinics are designed to feel calm and private, with each patient receiving consistent support across the network. Operating across multiple markets allows local expertise to be reinforced by regional standards, ensuring both personalisation and excellence.
A pivotal turning point came when Wang and her investors decided to narrow the company’s focus entirely on Asia, allowing for deep, thoughtful development in a region with growing demand. Opening the first clinic in Manila, complete with a vibrant community launch, marked another milestone. Looking ahead, Wang aims to make GenPrime the most trusted name in 88 family building across the region.
More from Tatler: Elevated matter: what sets Nature Squared’s sustainable design practices apart
Q&A
What inspired you to start your business? Was there a specific gap or opportunity in the market that others overlooked?
The starting point was actually quite personal. I froze my eggs in New York several years ago, and later started exploring what the process looked like in Southeast Asia. That experience made me realise how different the journey could feel depending on where you were.
The region has many excellent fertility doctors and embryologists doing important work. What struck me was that the overall experience around that care often felt fragmented. People are usually researching quietly for years before they ever see a doctor, and then once they do, diagnostics, consultations, and treatment can happen across multiple places.
I felt there was an opportunity to build something more connected—a place where people could start with questions and, if they choose to move forward, continue through diagnostics and treatment within the same ecosystem. The goal was to pair strong clinical standards with a more thoughtful, human experience of care.
In the early days, what were the biggest challenges you faced in building the company or brand?
There were so many challenges in the early days! Fertility is a very specialised field, and we set out to build across multiple markets from the start. That meant navigating a lot of ambiguity—every country approaches fertility care a little differently, whether in regulation, medical practice, or even cultural attitudes toward treatment.
At the same time, it’s a field where precision matters enormously. You can’t improvise your way through embryology labs or clinical governance, so a lot of our early focus was simply on building the right foundations.
What mattered most in the end was the team. Fertility care is deeply collaborative, and bringing together doctors, embryologists, nurses and operators who shared the same philosophy of patient care was paramount. Once that alignment was there, things started to take shape.
What sets your business apart from competitors?
For us, it starts with how the experience feels for patients.
Fertility treatment can be one of the most emotional journeys someone goes through, and we wanted our clinics to feel calm, private, and thoughtful—not overly clinical. The design of the space, the way appointments flow, even the lighting and layout all matter more than people realise.
But just as important is how patients experience the team. Fertility care works best when people feel genuinely supported and understood, so our doctors, embryologists, nurses, and coordinators work very closely with patients rather than operating in silos.
And because GenPrime operates across several markets in the region, we’re also able to connect expertise and standards across the network. Patients still receive care from local doctors who understand their community, but they’re supported by the strength of a broader regional platform.
Can you share a pivotal turning point such as a major risk, setback or breakthrough that significantly changed your company’s direction or growth trajectory?
In the very beginning, our ambitions were actually much broader. We had imagined building a truly global reproductive health platform with clinics across the Americas, Europe and Asia.
At one point, our investors gave us some very candid advice—which we’re grateful for. They reminded us that fertility care is incredibly complex, and building something meaningful in this field requires real depth of focus.
That conversation ended up being a turning point. We made the decision to concentrate entirely on Asia, which is such an exciting region for fertility care. Demand is growing quickly, the medical talent here is exceptional, and there’s still an enormous opportunity to improve how care is delivered.
Looking back, narrowing our focus was one of the best decisions we made. It allowed us to build more thoughtfully—and we’ve genuinely fallen in love with building in this part of the world.
How do you navigate through the changing economic, political and social climate?
Healthcare is always shaped by broader social change. People today are building their careers, relationships and families differently from previous generations, and family planning timelines are shifting alongside that.
One thing we’ve been very intentional about is focusing on cosmopolitan cities—Manila, Bangkok, Kuala Lumpur, Singapore and Los Angeles. These urban centres tend to share many of the same trends: people starting families later, more global mobility, and a growing openness to fertility care.
So we tend to grow in a metro-led way. Building in cities where these shifts are happening most visibly helps us stay close to how fertility needs are evolving, while still working thoughtfully within each local medical and regulatory environment.
Wherever we build, the goal is the same—excellent medicine, delivered in a way that feels calm, personal and deeply respectful of what people are going through.
As you look toward 2026, what is your long-term vision for the business?
Our mission has always been to elevate reproductive health for intended parents around the world. Fertility care sits at the centre of one of the most meaningful decisions people will ever make—starting a family—and we believe it deserves far more attention, innovation and compassion than it has traditionally received.
In the coming years, our focus is to keep deepening our presence across Asia and continuing to build thoughtfully in the region. There is extraordinary medical talent here, and the need for high-quality fertility care is growing quickly as more people choose to build families later in life.
Our ambition is bold but very simple: we want GenPrime to become the most trusted name in family building. The place people think of first when they need help conceiving—and the place they instinctively recommend to friends who are on the same journey.
Continuing Tatler’s 25th anniversary celebration, we honour 25 entrepreneurs whose ingenuity, resilience and purpose are reshaping the Philippine business landscape. Many started from humble beginnings, yet their determination and innovation have earned them well-deserved acclaim. Driven to make life better for the Filipino people, they are setting new standards for success.





